These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36758719)

  • 1. Addressing Administrative and System-Level Challenges to Implementation of Long-Acting Reversible Contraceptives in Adolescent Medicine and Pediatric and Adolescent Gynecology Practices: A Qualitative Study.
    Lunde B; Kaznoch D; Mahoney N; Akers AY; Rome ES
    J Pediatr Adolesc Gynecol; 2023 Jun; 36(3):304-310. PubMed ID: 36758719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana.
    Henry D; Wood S; Moshashane N; Ramontshonyana K; Amutah C; Maleki P; Howlett C; Brooks MJ; Mussa A; Joel D; Steenhoff AP; Akers AY; Morroni C
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):504-513. PubMed ID: 33766793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
    Davis SA; Braykov NP; Lathrop E; Haddad LB
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Pediatricians Provide Long-Acting Reversible Contraception?
    Norris AH; Pritt NM; Berlan ED
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Delaware Contraceptive Access Now (DelCAN) initiative: A qualitative analysis of site leaders' implementation recommendations.
    Skračić I; Lewin AB; Roy KM
    Contraception; 2021 Aug; 104(2):211-215. PubMed ID: 33762171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
    Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New york city physicians' views of providing long-acting reversible contraception to adolescents.
    Rubin SE; Davis K; McKee MD
    Ann Fam Med; 2013; 11(2):130-6. PubMed ID: 23508599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Long-Acting Reversible Contraception Services into New York City School-Based Health Centers: Quality Improvement to Ensure Provision of Youth-Friendly Services.
    Sangraula M; Garbers S; Garth J; Shakibnia EB; Timmons S; Gold MA
    J Pediatr Adolesc Gynecol; 2017 Jun; 30(3):376-382. PubMed ID: 27871920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Providing long-acting reversible contraception services in Seattle school-based health centers: key themes for facilitating implementation.
    Gilmore K; Hoopes AJ; Cady J; Amies Oelschlager AM; Prager S; Vander Stoep A
    J Adolesc Health; 2015 Jun; 56(6):658-65. PubMed ID: 26003582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico.
    Palm HC; Degnan JH; Biefeld SD; Reese AL; Espey E; Hofler LG
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S911.e1-S911.e7. PubMed ID: 31978431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 12. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
    Coates C; Gordon CM; Simpson T
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive Procedures in Internal Medicine Clinics and Resident Education: a Qualitative Study of Implementation Methods, Barriers, and Facilitators.
    Casas RS; Prifti CA; Bachorik AE; Stuckey H; Sobota M; Chuang CH; Weisman CS
    J Gen Intern Med; 2021 Nov; 36(11):3346-3352. PubMed ID: 33959883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.
    Hoopes AJ; Gilmore K; Cady J; Akers AY; Ahrens KR
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):259-64. PubMed ID: 26477942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
    Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
    BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients.
    Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL
    J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences on Intentions to Place Long-Acting Reversible Contraceptives: A Pilot Study Comparing According to Provider Specialty in Ohio.
    Thompson CM; Broecker J; Dade M; Nottingham K
    J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):509-515. PubMed ID: 29580916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and acceptability of a toolkit-based process to implement patient-centered, immediate postpartum long-acting reversible contraception services.
    Moniz MH; Dalton VK; Smith RD; Owens LE; Landis-Lewis Z; Peahl AF; Van Kainen B; Punch MR; Wetmore MK; Bonawitz K; Kolenic GE; Dehlendorf C; Heisler M
    Am J Obstet Gynecol; 2022 Mar; 226(3):394.e1-394.e16. PubMed ID: 34655551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "This has definitely opened the doors": Provider perceptions of patient experiences with telemedicine for contraception in Illinois.
    Song B; Boulware A; Wong ZJ; Huang I; Whitaker AK; Hasselbacher L; Stulberg D
    Perspect Sex Reprod Health; 2022 Sep; 54(3):80-89. PubMed ID: 36071608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of an Implementation Science Framework to Policies on Immediate Postpartum Long-Acting Reversible Contraception.
    DeSisto CL; Kroelinger CD; Estrich C; Velonis A; Uesugi K; Goodman DA; Pliska E; Akbarali S; Rankin KM
    Public Health Rep; 2019; 134(2):189-196. PubMed ID: 30699303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.